MPTs: Articles
from the Field

15 May 2014


To our CAMI Colleagues,


Greetings! The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. In order to keep you informed, we will be sending periodic updates via "MPTs: Articles from the Field" with links to recent publications, media articles and press releases on MPTs. This first update includes resources published since January 2014. Please send your relevant articles on MPTs to Marisa Cheung at [email protected] to be included in the next issue.




CAMI Staff 


Journal Articles

Adherence in the CAPRISA 004 Tenofovir Gel Microbicide Trial. Mansoor, L. E., Karim, Q. A., Yende-Zuma, N., MacQueen, K. M., Baxter, C., Madlala, B. T., ... & Karim, S. S. A. (2014). AIDS and behavior, 18(5), 811-819.

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. Terris-Prestholt, F., Foss, A. M., Cox, A. P., Heise, L., Meyer-Rath, G., Delany-Moretlwe, S., ... & Watts, C. H. (2014). BMC infectious diseases, 14(1), 14.


Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection. McConville, C., Boyd, P., & Major, I. (2014). Clinical medicine insights. Women's health, 7, 1. doi: 10.4137/CMWH.S10353


Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy. Clark, J. T., Clark, M. R., Shelke, N. B., Johnson, T. J., Smith, E. M., Andreasen, A. K., ... & Kiser, P. F. (2014). PloS one, 9(3), e88509.


Long-lasting contraceptive also defends women from HIV. Thompson H. (2014, March 5). NewScientist. 

Long-lasting device protects against HIV, pregnancy. Northwestern University. (2014, March 5). ScienceDaily. 


Multipurpose prevention technologies: maximising positive synergies. Lusti-Narasimhan, M., Merialdi, M., & Holt, B. (2014). BJOG: An International Journal of Obstetrics & Gynaecology, 121(3), 251-251. doi: 10.1111/1471-0528.12606


A Potent Combination Microbicide that Targets SHIV-RT, HSV-2 and HPV. Kizima, L., Rodr�guez, A., Kenney, J., Derby, N., Mizenina, O., Menon, R., ... & Fern�ndez-Romero, J. A. (2014). A Potent Combination Microbicide that Targets SHIV-RT, HSV-2 and HPV. PloS one, 9(4), e94547. doi:10.1371/journal.pone.0094547 


Qualitative research from the VOICE trial reveals women's challenges in adherence. van der Straten A., Stadler J., Montgomery E., Hartmann M., Magazi B., Mathebula F., Schwartz K., Laborde N., & Soto-Torres L. (2014).  PLoS One. 9(2):e89118. doi: 10.1371/journal.pone.0089118. 


Two Studies Advance HIV Prevention Options for Women. International Partnership for Microbicides. (2014, March 4). 


MPTs in the Media



MPTs are innovative strategies to transform women's health. Shukla, S. (2014, April 28). Citizen News Service.  


Multipurpose Prevention Technologies Can Transform Women's Health.

Shukla, S. (2014, January 22). Citizen News Service. 

New vaginal cream blocks HIV transmission. Anderson-Minshall, D. (2014, February 3). HIV 


Thinking beyond the pill. (2014, January 1). New York Times. 


Press Release


IPM receives worldwide rights to HIV prevention medicine. The International Partnership for Microbicides. (2014, May 8). Phys.Org Science News Wire.



Visit and
for more resources on MPTs.

Facebook   Twitter

IMPT Secretariat: CAMI

312 Natoma Street, Suite 150
Folsom, CA 95630
[email protected]